Free Trial

Kyverna Therapeutics (KYTX) Earnings Date, Estimates & Call Transcripts

Kyverna Therapeutics logo
$2.27 -0.20 (-8.10%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.26 -0.01 (-0.44%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kyverna Therapeutics Earnings Summary

Kyverna Therapeutics announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$1.03, which beat analysts' consensus estimates of -$1.21 by $0.18. With a trailing EPS of -$3.38, Kyverna Therapeutics' earnings are expected to decrease next year, from ($3.29) to ($3.73) per share.

Upcoming Q2
Earnings Date
Aug. 11Before Market OpensEstimated
Consensus EPS
(May. 13)
-$1.21
Actual EPS
(May. 13)
-$1.03 Beat By $0.18

Q1 2025 Earnings Resources

KYTX Upcoming Earnings

Kyverna Therapeutics' next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules.

Get Kyverna Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kyverna Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

KYTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Kyverna Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.87-$0.87-$0.87
Q2 20252-$0.92-$0.87-$0.90
Q3 20252-$0.77-$0.76-$0.77
Q4 20252-$0.83-$0.77-$0.80
FY 2025 7 -$3.39 -$3.27 -$3.33
Q1 20261-$0.87-$0.87-$0.87
Q2 20261-$0.91-$0.91-$0.91
Q3 20261-$0.96-$0.96-$0.96
Q4 20261-$0.88-$0.88-$0.88

Kyverna Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2025
(Estimated)
--------
5/13/2025Q1 2025-$1.21-$1.03+$0.18-$1.03--
3/27/2025Q4 2024-$0.87-$0.88 -$0.01-$0.88--
11/13/2024--$0.81-$0.80+$0.01--$0.01M
8/12/2024Q2 2024-$0.70-$0.67+$0.03-$0.67$3.75M-
5/14/2024Q1 2024-$0.84-$1.12 -$0.28-$1.12$3.75M-

Kyverna Therapeutics Earnings - Frequently Asked Questions

Kyverna Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on KYTX's earnings history.

In the previous quarter, Kyverna Therapeutics (NASDAQ:KYTX) reported ($1.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.21) by $0.18. Learn more on analysts' earnings estimate vs. KYTX's actual earnings.

Kyverna Therapeutics (NASDAQ:KYTX) has a recorded annual revenue of $7.03 million.

Kyverna Therapeutics (NASDAQ:KYTX) has a recorded net income of -$60.37 million. KYTX has generated -$3.38 earnings per share over the last four quarters.

Kyverna Therapeutics's earnings are expected to decrease from ($3.29) per share to ($3.73) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:KYTX) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners